Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
Authors
Keywords
-
Journal
Frontiers in Cardiovascular Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-11-11
DOI
10.3389/fcvm.2021.754499
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction
- (2021) Thomas M. Maddox et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure
- (2021) Biykem Bozkurt et al. EUROPEAN JOURNAL OF HEART FAILURE
- CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
- (2021) Michael McDonald et al. CANADIAN JOURNAL OF CARDIOLOGY
- IMPACT OF CARDIOVASCULAR AND NON-CARDIOVASCULAR HOSPITALIZATION ON QUALITY OF LIFE IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION
- (2020) Carisi Anne Polanczyk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan
- (2020) James L. Januzzi et al. Circulation-Heart Failure
- Effect of Sacubitril-Valsartan in reducing depression in patients with advanced heart failure
- (2020) Francesco Cacciatore et al. JOURNAL OF AFFECTIVE DISORDERS
- Left-Ventricular Function After 3 Months of Sacubitril-Valsartan in Acute Decompensated Heart Failure
- (2020) Dino Mirić et al. Journal of Cardiovascular Translational Research
- NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction
- (2020) Domingo Pascual-Figal et al. JACC-Heart Failure
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal function dynamics following co‐administration of sacubitril/valsartan and empagliflozin in patients with heart failure and type 2 diabetes
- (2020) Rafael Espriella et al. ESC Heart Failure
- Heart failure in the last year: progress and perspective
- (2020) Daniela Tomasoni et al. ESC Heart Failure
- Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction
- (2020) Sean P. Murphy et al. JACC-Heart Failure
- Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: The PRIME Study
- (2019) Duk-Hyun Kang et al. CIRCULATION
- Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study
- (2019) Clare J Taylor et al. BMJ-British Medical Journal
- Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF
- (2019) Michael R. Zile et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts
- (2019) Ryan M. Burke et al. Circulation-Heart Failure
- Neprilysin inhibition: a new therapeutic option for type 2 diabetes?
- (2019) Nathalie Esser et al. DIABETOLOGIA
- Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study
- (2019) Rolf Wachter et al. EUROPEAN JOURNAL OF HEART FAILURE
- Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology
- (2019) Petar M. Seferovic et al. EUROPEAN JOURNAL OF HEART FAILURE
- Screening and Management of Depression in Patients With Cardiovascular Disease
- (2019) Manish K. Jha et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Early Effects of Sacubitril/Valsartan on Exercise Tolerance in Patients with Heart Failure with Reduced Ejection Fraction
- (2019) Giuseppe Vitale et al. Journal of Clinical Medicine
- Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients With Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator
- (2019) Milton Packer Circulation-Arrhythmia and Electrophysiology
- Effects of the Angiotensin‐Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta‐Analysis
- (2019) Yiwen Wang et al. Journal of the American Heart Association
- Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction
- (2019) Akshay S. Desai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction
- (2019) James L. Januzzi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed ( de novo ) heart failure: a subgroup analysis of the TRANSITION study
- (2019) Michele Senni et al. EUROPEAN JOURNAL OF HEART FAILURE
- Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF)
- (2018) James L. Januzzi et al. AMERICAN HEART JOURNAL
- The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction
- (2018) Pieter Martens et al. Cardiovascular Therapeutics
- Effects of Sacubitril/Valsartan Versus Irbesartan in Patients with Chronic Kidney Disease: A Randomised Double-Blind Trial
- (2018) Richard Haynes et al. CIRCULATION
- Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure)
- (2018) Eileen O’Meara et al. Circulation-Heart Failure
- Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)
- (2018) Ulrik M. Mogensen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2018) Petar M. Seferović et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices
- (2018) Carlos de Diego et al. HEART RHYTHM
- Correlation of the New York Heart Association classification and the cardiopulmonary exercise test: A systematic review
- (2018) Fang Yi Lim et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Sacubitril/valsartan and short-term changes in the 6-minute walk test: A pilot study
- (2018) Paola Beltrán et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The clinical profile of a non-selected population treated with sacubitril/valsartan is different from PARADIGM-HF trial
- (2018) Lourdes Vicent et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States
- (2018) Patrick M. Zueger et al. PHARMACOTHERAPY
- Combined Angiotensin Receptor–Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure
- (2018) Rishi K. Trivedi et al. Journal of the American Heart Association
- Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial
- (2018) Milton Packer et al. Lancet Diabetes & Endocrinology
- Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure
- (2018) Kevin Damman et al. JACC-Heart Failure
- Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure
- (2018) Alvin Chandra et al. JAMA Cardiology
- Is Sacubitril/Valsartan (Also) an Antiarrhythmic Drug?
- (2018) Axel Sarrias et al. CIRCULATION
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Effect of sacubitril/valsartan on cardiac filling pressures in patients with left ventricular systolic dysfunction
- (2018) Zubair Khan et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- ST2 in Heart Failure
- (2018) Antoni Bayés-Genis et al. Circulation-Heart Failure
- Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study
- (2018) Hélène Nougué et al. EUROPEAN JOURNAL OF HEART FAILURE
- Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial
- (2018) Brian P Halliday et al. LANCET
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
- (2018) Eric J. Velazquez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF
- (2017) Michael Böhm et al. EUROPEAN HEART JOURNAL
- Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization
- (2017) Josep Lupón et al. EUROPEAN JOURNAL OF HEART FAILURE
- Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides
- (2017) Emilia D'Elia et al. EUROPEAN JOURNAL OF HEART FAILURE
- Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF
- (2017) Ulrik M. Mogensen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Soluble ST2 for Prognosis and Monitoring in Heart Failure
- (2017) Antoni Bayés-Genís et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Declining Risk of Sudden Death in Heart Failure
- (2017) Li Shen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers
- (2017) Ravi Dhingra et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial
- (2017) Jelena P Seferovic et al. Lancet Diabetes & Endocrinology
- Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril
- (2017) Akshay S. Desai et al. JAMA Cardiology
- Importance of Clinical Worsening of Heart Failure Treated in the Outpatient SettingCLINICAL PERSPECTIVE
- (2016) Naoki Okumura et al. CIRCULATION
- Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis
- (2016) Scott D. Solomon et al. EUROPEAN JOURNAL OF HEART FAILURE
- Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens
- (2016) Michele Senni et al. EUROPEAN JOURNAL OF HEART FAILURE
- Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy
- (2016) Javier Díez EUROPEAN JOURNAL OF HEART FAILURE
- Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization
- (2016) Akshay S. Desai et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure
- (2016) Michael R. Zile et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Long-term neprilysin inhibition — implications for ARNIs
- (2016) Duncan J. Campbell Nature Reviews Cardiology
- Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation
- (2016) Scott D. Solomon et al. JACC-Heart Failure
- Correlation of the New York Heart Association Classification and the 6-Minute Walk Distance: A Systematic Review
- (2015) Jonathan Yap et al. CLINICAL CARDIOLOGY
- Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
- (2015) Akshay S. Desai et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF
- (2015) Pardeep S. Jhund et al. EUROPEAN HEART JOURNAL
- Combined neprilysin and RAS inhibition for the failing heart: straining the kidney to help the heart?
- (2015) Piero Ruggenenti et al. EUROPEAN JOURNAL OF HEART FAILURE
- Mean HbA1cand mortality in diabetic individuals with heart failure: a population cohort study
- (2015) Douglas H.J. Elder et al. EUROPEAN JOURNAL OF HEART FAILURE
- The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: Results of the REVERSE study
- (2015) Michael R. Gold et al. HEART RHYTHM
- Association of heart failure severity with risk of diabetes: a Danish nationwide cohort study
- (2014) Malene N. Demant et al. DIABETOLOGIA
- Neprilysin inhibition in chronic kidney disease
- (2014) P. Judge et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2013) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Heart Failure
- (2013) Eugene Braunwald JACC-Heart Failure
- Lifetime Analysis of Hospitalizations and Survival of Patients Newly Admitted With Heart Failure
- (2012) Soohun Chun et al. Circulation-Heart Failure
- The Three-Phase Terrain of Heart Failure Readmissions
- (2012) Akshay S. Desai Circulation-Heart Failure
- Modest Increase in Peak VO 2 Is Related to Better Clinical Outcomes in Chronic Heart Failure Patients
- (2012) Ann M. Swank et al. Circulation-Heart Failure
- The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
- (2012) Scott D Solomon et al. LANCET
- Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Effect of Aldosterone Antagonism With Eplerenone on Ventricular Remodeling in Patients With Mild-to-Moderate Heart Failure and Left Ventricular Systolic Dysfunction
- (2010) James E. Udelson et al. Circulation-Heart Failure
- Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction
- (2010) Daniel G. Kramer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study
- (2010) Luis Miguel Ruilope et al. LANCET
- Cardiac Resynchronization Induces Major Structural and Functional Reverse Remodeling in Patients With New York Heart Association Class I/II Heart Failure
- (2009) Martin St. John Sutton et al. CIRCULATION
- Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure
- (2009) Corinna Bergamini et al. EUROPEAN JOURNAL OF HEART FAILURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now